Structure-Activity Relationship and Molecular Docking of Natural Product Library Reveal Chrysin as a Novel Dipeptidyl Peptidase-4 (DPP-4) Inhibitor: An Integrated In Silico and In Vitro Study

被引:45
|
作者
Kalhotra, Poonam [1 ]
Chittepu, Veera C. S. R. [2 ]
Osorio-Revilla, Guillermo [2 ]
Gallardo-Velazquez, Tzayhri [1 ]
机构
[1] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Biofis, Prolongac Carpio & Plan Ayala S-N Col Santo Tomas, Mexico City 11340, DF, Mexico
[2] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Av Wilfrido Massieu S-N, Mexico City 07738, DF, Mexico
来源
MOLECULES | 2018年 / 23卷 / 06期
关键词
natural products; field-based virtual screening; structure-activity relationship model; molecular docking; dipeptidyl peptidase-4 enzyme; DATABASES; LIGANDS; INJURY;
D O I
10.3390/molecules23061368
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Numerous studies indicate that diets with a variety of fruits and vegetables decrease the incidence of severe diseases, like diabetes, obesity, and cancer. Diets contain a variety of bioactive compounds, and their features, like diverge scaffolds, and structural complexity make them the most successful source of potential leads or hits in the process of drug discovery and drug development. Recently, novel serine protease dipeptidyl peptidase-4 (DPP-4) inhibitors played a role in the management of diabetes, obesity, and cancer. This study describes the development of field template, field-based qualitative structure-activity relationship (SAR) model demonstrating DPP-4 inhibitors of natural origin, and the same model is used to screen virtually focused food database composed of polyphenols as potential DPP-4 inhibitors. Compounds' similarity to field template, and novelty score "high and very high", were used as primary criteria to identify novel DPP-4 inhibitors. Molecular docking simulations were performed on the resulting natural compounds using FlexX algorithm. Finally, one natural compound, chrysin, was chosen to be evaluated experimentally to demonstrate the applicability of constructed SAR model. This study provides the molecular insights necessary in the discovery of new leads as DPP-4 inhibitors, to improve the potency of existing DPP-4 natural inhibitors.
引用
收藏
页数:11
相关论文
共 41 条
  • [1] Quantitative Structure-Activity Relationship and Molecular Docking Studies of Imidazolopyrimidine Amides as Potent Dipeptidyl Peptidase-4 (DPP4) Inhibitors
    Emami, Leila
    Sabet, Razieh
    Sakhteman, Amirhossein
    Zade, Mehdi Khoshnevis
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2019, 27 (06)
  • [2] VIRTUAL SCREENING AND IN VITRO ASSAYS OF LIGANDS WITH ACTIVITY AGAINST DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME
    Pantaleao, Simone Queiroz
    Philot, Eric Allison
    De Paula, Heberth
    De Sairre, Mirela Ines
    Lima, Angelica Nakagawa
    Dos Santos, Raquel Alves
    Scott, Ana Ligia
    Honorio, Kathia Maria
    [J]. BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1332 - 1332
  • [3] Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation
    Meduru, Harika
    Wang, Yeng-Tseng
    Tsai, Jeffrey J. P.
    Chen, Yu-Ching
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (06):
  • [4] Inhibition of Dipeptidyl Peptidase-4 by Flavonoids: Structure-Activity Relationship, Kinetics and Interaction Mechanism
    Pan, Junkun
    Zhang, Qiang
    Zhang, Chunling
    Yang, Wenbo
    Liu, Hui
    Lv, Zhenzhen
    Liu, Jiechao
    Jiao, Zhonggao
    [J]. FRONTIERS IN NUTRITION, 2022, 9
  • [5] Research Progress on the Synthesis and Structure-Activity Relationship of Five Hypoglycemic Active Heterocycles Based on Dipeptidyl Peptidase 4 (DPP-4) Target Design
    Kong, Yuanfang
    Yang, Bin
    Zhuang, Yan
    Zhang, Jingyu
    Sun, Demei
    Dong, Chunhong
    [J]. CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2022, 42 (03) : 770 - 784
  • [6] α-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of Melicope latifolia bark extracts and identification of bioactive constituents using in vitro and in silico approaches
    Quek, Alexandra
    Kassim, Nur Kartinee
    Lim, Pei Cee
    Tan, Dai Chuan
    Mohammad Latif, Muhammad Alif
    Ismail, Amin
    Shaari, Khozirah
    Awang, Khalijah
    [J]. PHARMACEUTICAL BIOLOGY, 2021, 59 (01) : 964 - 973
  • [7] Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure-activity relationship-based artificial intelligence and molecular docking of hit compounds
    Hermansyah, Oky
    Bustamam, Alhadi
    Yanuar, Arry
    [J]. COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2021, 95
  • [8] Design, Synthesis and Biological Evaluation of Neogliptin, a Novel 2-Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4)
    Maslov, Ivan O.
    Zinevich, Tatiana, V
    Kirichenko, Olga G.
    Trukhan, Mikhail, V
    Shorshnev, Sergey, V
    Tuaeva, Natalya O.
    Gureev, Maxim A.
    Dahlen, Amelia D.
    Porozov, Yuri B.
    Schioth, Helgi B.
    Trukhan, Vladimir M.
    [J]. PHARMACEUTICALS, 2022, 15 (03)
  • [9] Fragment-Based Drug Design to Discover Novel Inhibitor of Dipeptidyl Peptidase-4 (DPP-4) as a Potential Drug for Type 2 Diabetes Therapy
    Ningsih, Eka Gunarti
    Hidayat, Muhammad Fauzi
    Tambunan, Usman Sumo Friend
    [J]. BIOINFORMATICS AND BIOMEDICAL ENGINEERING, IWBBIO 2019, PT I, 2019, 11465 : 14 - 24
  • [10] Effects of Age, Gender and Obesity on the Single Dose Pharmacokinetics (PK) of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
    Addy, Carol
    Tatosian, Daniel
    Hou, Xiaoli S.
    Gendrano, Isaias N.
    Martucci, Ashley
    Wagner, John A.
    Stoch, S. Aubrey
    [J]. DIABETES, 2013, 62 : A301 - A301